- Home
- MTEX vs ENLV Comparison
MTEX vs ENLV Comparison
Compare MTEX & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- ENLV
- Stock Information
- Founded
- MTEX 1993
- ENLV 2005
- Country
- MTEX United States
- ENLV Israel
- Employees
- MTEX N/A
- ENLV N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- ENLV Health Care
- Exchange
- MTEX Nasdaq
- ENLV Nasdaq
- Market Cap
- MTEX 19.9M
- ENLV 20.7M
- IPO Year
- MTEX 1999
- ENLV 1995
- Fundamental
- Price
- MTEX $10.00
- ENLV $1.04
- Analyst Decision
- MTEX
- ENLV Strong Buy
- Analyst Count
- MTEX 0
- ENLV 2
- Target Price
- MTEX N/A
- ENLV $10.00
- AVG Volume (30 Days)
- MTEX 1.7K
- ENLV 51.4K
- Earning Date
- MTEX 05-20-2025
- ENLV 06-13-2025
- Dividend Yield
- MTEX N/A
- ENLV N/A
- EPS Growth
- MTEX N/A
- ENLV N/A
- EPS
- MTEX 1.32
- ENLV N/A
- Revenue
- MTEX $117,866,000.00
- ENLV N/A
- Revenue This Year
- MTEX N/A
- ENLV N/A
- Revenue Next Year
- MTEX N/A
- ENLV N/A
- P/E Ratio
- MTEX $7.58
- ENLV N/A
- Revenue Growth
- MTEX N/A
- ENLV N/A
- 52 Week Low
- MTEX $6.75
- ENLV $0.81
- 52 Week High
- MTEX $16.49
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- MTEX 49.29
- ENLV 55.34
- Support Level
- MTEX $9.70
- ENLV $1.03
- Resistance Level
- MTEX $11.90
- ENLV $1.15
- Average True Range (ATR)
- MTEX 0.26
- ENLV 0.06
- MACD
- MTEX -0.03
- ENLV 0.02
- Stochastic Oscillator
- MTEX 24.00
- ENLV 63.09
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.